Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01957735
What this trial is testing

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

Who this might be right for
Metastatic CancerCancerSolid Tumor
BPGbio 97
Not applicableActive Not RecruitingNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Not applicableUnknownNCT01638130
What this trial is testing

Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers

Who this might be right for
Brain Neoplasms, Primary Malignant
Universitaire Ziekenhuizen KU Leuven 30
Testing effectiveness (Phase 2)Ended earlyNCT00910039
What this trial is testing

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Ended earlyNCT00096265
What this trial is testing

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 126
Testing effectiveness (Phase 2)Study completedNCT02755142
What this trial is testing

Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas

Who this might be right for
Brain Neoplasm
medac GmbH 21
Testing effectiveness (Phase 2)Study completedNCT00025675
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Not applicableLooking for participantsNCT04908709
What this trial is testing

Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors

Who this might be right for
Malignant Brain Glioma
Emory University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04804644
What this trial is testing

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Who this might be right for
Metastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainRecurrent Lung Small Cell Carcinoma+1 more
NRG Oncology 152
Testing effectiveness (Phase 2)Study completedNCT00990652
What this trial is testing

Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 10
Large-scale testing (Phase 3)Study completedNCT00030628
What this trial is testing

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Alliance for Clinical Trials in Oncology 480
Large-scale testing (Phase 3)Study completedNCT00003563
What this trial is testing

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Pharmacyclics LLC. 430
Early research (Phase 1)Study completedNCT01491893
What this trial is testing

PVSRIPO for Recurrent Glioblastoma (GBM)

Who this might be right for
GBMGlioblastomaGlioma+1 more
Istari Oncology, Inc. 61
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Not applicableStudy completedNCT00943007
What this trial is testing

Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors

Who this might be right for
Glioblastoma Multiforme
Maastricht University Medical Center 14
Not applicableLooking for participantsNCT06474533
What this trial is testing

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

Who this might be right for
Intracranial Neoplasm
Thomas Hope 199
Testing effectiveness (Phase 2)Ended earlyNCT00227656
What this trial is testing

Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00022724
What this trial is testing

CCI-779 in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 49
Next Page